MED12 and Miyoshi myopathy: Because MED12-dependent CDK8/19 activation regulates enhancer-promoter interactions and CDK8 appears to function as a barrier to cellular reprogramming [14, 43], we sought to determine if DEGs identified in Mediator kinase-inhibited MM SCs could be explained by altered enhancer activity.